ACS是否应该早期介入治疗.pptVIP

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
ACS是否应该早期介入治疗

Is early invasive the answer for ACS Dr. Ben He MD/PhD/FSCAI/FAPSIC Director of Cardiology Department Renji Hospital Affiliated to Shanghai Jiaotong university ACS is an Important Manifestation of Atherothrombosis1 Relation of TIMI risk score and MACE rate Hot topic in ACS Is early invasive superior to conservative strategy in ACS? Should invasive be deferred for cooling off? What is the optimal time for invasive? Optimal Strategy for UA/NSTEMI FRICS-II: high risk get more TIMI-18: high risk get more RITA-3: 13 yrs outcome RITA-3: 5yrs outcome In 2005,It seems we found answer In ACS, early invasive superior to early conservative This is particular true in high risk patients ESC Guideline 2005 Is the problem settled? ICTUS Designed ICTUS’s criticism Liberty definition of MI (only 1*ULN) causing the early MI increase in early invasive group 3yrs revascularization rate was equal in 2 group(81%PCI) 1year mortality rate in ACS in both arm are very low(2.5%),Is it a real high risk? Even put ICTUS into pool, Inv Cons Inv vs Cons/All cause death 2007 ESC Guideline Urgent Coronary angiography is recommended in Pts with refractory or recurrent angina associated with dynamic ST deviation, heart failure, life threatening arrhythmias, or haemodynamic instability (I-C) Early(72h) angiography followed by revascularization (PCI or CABG) in patients with intermediate to high risk features is recommended (I-A) ISAR-COOL Trial ISAR-COOL Antithrombotic Regimen ISAR-COOL What is the optimal time for PCI? Methods for Optimal trial Results of Optimal trial Conclusion from Optimal trial What’s the difference between ISAR-Cool Optimal? Time to Coronary Angiography and Outcomes Among Patients With High-Risk Non–ST-Segment–Elevation Acute Coronary Syndromes: Results From the SYNERGY Trial Pierluigi Tricoci, MD, MHS, PhD; Yuliya Lokhnygina, PhD; Lisa G. Berdan, PA-C, MHS; Steven R. Steinhubl, MD; Dietrich C. Gulba, MD; Harvey D. White, MD; Neal S. Kleiman, MD; Philip E. Aylw

文档评论(0)

qiwqpu54 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档